Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy

Sikai Ling; Xue Zhang; Yao Dai; Zhuofan Jiang; Xujiao Zhou; Sicong Lu; Xiaoqing Qian; Jianping Liu; Niklas Selfjord; Tugce Munise Satir; Anders Lundin; Julia Liz Touza; Mike Firth; Natalie Van Zuydam; Bilada Bilican; Pinar Akcakaya; Jiaxu Hong; Yujia Cai

doi:https://doi.org/10.1038/s41565-024-01851-7

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy

Identifier:nobleid.org/w1/20260418/28906863

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/28906863.svg?ark=w1%2F20260418%2F28906863)](https://nobleid.org/work/w1/20260418/28906863)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy

Identifier:nobleid.org/w1/20260418/28906863

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/28906863.svg?ark=w1%2F20260418%2F28906863)](https://nobleid.org/work/w1/20260418/28906863)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work